Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide

NCT02714634 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

286

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Insufficient Response to Methotrexate or Leflunomide

Interventions

DRUG: Methotrexate + targeted therapy administration
DRUG: methotrexate or leflunomide + sulfasalazine + hydroxychloroquine administration

Sponsor

University Hospital, Strasbourg, France